Article info

Download PDFPDF
Original article
SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer

Authors

  • Ledong Wan Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles
  • Wenying Yu State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Enhui Shen College of Agriculture and Biotechnology, Institute of Bioinformatics, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles
  • Wenjie Sun Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles
  • Yuan Liu Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles
  • Jianlu Kong Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles
  • Yihua Wu Department of Toxicology, School of Public Health, Zhejiang University, Hangzhou, Zhejiang, China PubMed articlesGoogle scholar articles
  • Fengyan Han Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles
  • Lei Zhang Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China Department of Pharmacology, China Pharmaceutical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Tianze Yu Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles
  • Yuwei Zhou Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles
  • Sunzhe Xie Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles
  • Enping Xu Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles
  • Honghe Zhang Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles
  • Maode Lai Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China Department of Pharmacology, China Pharmaceutical University, Nanjing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Honghe Zhang and Prof. Maode Lai, Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou 310058, China; honghezhang{at}zju.edu.cn, lmp{at}zju.edu.cn
View Full Text

Citation

Wan L, Yu W, Shen E, et al
SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer

Publication history

  • Received August 2, 2017
  • Revised September 25, 2017
  • Accepted October 21, 2017
  • First published November 7, 2017.
Online issue publication 
June 15, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.